Exploring ways to prevent and treat obesity using dietary compounds
Administrative Core
This study is exploring how certain healthy food compounds can help prevent and treat obesity and its related health problems, and it's designed for anyone looking to improve their health through better eating habits.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Nebraska Lincoln NIH-funded |
| Lab location | 1 site (Lincoln, United States) |
| Project ID | NIH-11117014 on NIH RePORTER |
What this research studies
This research focuses on the Nebraska Center for the Prevention of Obesity Diseases through Dietary Molecules, which aims to prevent, treat, and cure obesity and its related health issues using bioactive food compounds. The project is building a strong infrastructure to support this mission, including a dedicated team of experts and advisory committees. Patients may benefit from innovative dietary interventions that could improve their health outcomes related to obesity and its co-morbidities. The research will involve collaboration among various faculty members and external advisors to ensure a comprehensive approach.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals struggling with obesity and related health conditions who are interested in dietary interventions.
Not a fit: Patients who are not affected by obesity or related co-morbidities may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new dietary strategies that significantly improve the management and prevention of obesity and related diseases.
How similar studies have performed: Previous research has shown promise in using dietary compounds to address obesity, indicating that this approach has potential for success.
Where this research is happening
Lincoln, United States
- University of Nebraska Lincoln — Lincoln, United States (Active)
Researchers
- Principal investigator: Zempleni, Janos — University of Nebraska Lincoln
- Study coordinator: Zempleni, Janos
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.